Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.

Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC.

J Neurosurg. 2012 Apr;116(4):843-53. doi: 10.3171/2011.11.JNS111455. Epub 2012 Feb 7.

PMID:
22313360
2.

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.

Safaee M, Clark AJ, Oh MC, Ivan ME, Bloch O, Kaur G, Sun MZ, Kim JM, Oh T, Berger MS, Parsa AT.

PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765. Print 2013.

3.

Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status.

Clark AJ, Dos Santos WG, McCready J, Chen MY, Van Meter TE, Ware JL, Wolber SB, Fillmore H, Broaddus WC.

J Neurosurg. 2007 Sep;107(3):586-92.

PMID:
17886559
4.

CD97 and glioma invasion.

Huang LC, Hueng DY.

J Neurosurg. 2014 Feb;120(2):579-80. doi: 10.3171/2012.11.JNS12437. Epub 2013 Nov 29. No abstract available.

PMID:
24286141
5.

CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.

Li C, Liu DR, Li GG, Wang HH, Li XW, Zhang W, Wu YL, Chen L.

World J Gastroenterol. 2015 May 28;21(20):6215-28. doi: 10.3748/wjg.v21.i20.6215.

6.

Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma.

Somasundaram A, Ardanowski N, Opalak CF, Fillmore HL, Chidambaram A, Broaddus WC.

Neurosurg Focus. 2014 Dec;37(6):E14. doi: 10.3171/2014.9.FOCUS14506. Review.

PMID:
25434383
7.

Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.

Safaee M, Fakurnejad S, Bloch O, Clark AJ, Ivan ME, Sun MZ, Oh T, Phillips JJ, Parsa AT.

PLoS One. 2015 Feb 25;10(2):e0111532. doi: 10.1371/journal.pone.0111532. eCollection 2015.

8.

Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.

Clark AJ, Ware JL, Chen MY, Graf MR, Van Meter TE, Dos Santos WG, Fillmore HL, Broaddus WC.

J Neurosurg. 2010 Jan;112(1):18-25. doi: 10.3171/2008.11.JNS08368.

PMID:
19392599
9.

STAT6 expression in glioblastoma promotes invasive growth.

Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM.

BMC Cancer. 2011 May 20;11:184. doi: 10.1186/1471-2407-11-184.

10.

Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.

Chen MY, Clark AJ, Chan DC, Ware JL, Holt SE, Chidambaram A, Fillmore HL, Broaddus WC.

J Neurooncol. 2011 May;103(1):87-102. doi: 10.1007/s11060-010-0374-7. Epub 2010 Sep 4.

11.

Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.

Mukherjee J, DeSouza LV, Micallef J, Karim Z, Croul S, Siu KW, Guha A.

Cancer Res. 2009 Nov 15;69(22):8545-54. doi: 10.1158/0008-5472.CAN-09-1778. Epub 2009 Nov 10.

12.

Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.

Seno T, Harada H, Kohno S, Teraoka M, Inoue A, Ohnishi T.

Int J Oncol. 2009 Mar;34(3):707-15.

PMID:
19212676
13.

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D.

Mol Cancer. 2010 Jun 1;9:133. doi: 10.1186/1476-4598-9-133.

14.

FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.

Dikshit B, Irshad K, Madan E, Aggarwal N, Sarkar C, Chandra PS, Gupta DK, Chattopadhyay P, Sinha S, Chosdol K.

Oncogene. 2013 Aug 15;32(33):3798-808.

PMID:
22986533
15.

Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.

Glienke W, Maute L, Wicht J, Bergmann L.

Eur J Cancer. 2009 Mar;45(5):874-80. doi: 10.1016/j.ejca.2008.12.030. Epub 2009 Feb 3.

PMID:
19196508
16.

WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1.

Lv L, Chen G, Zhou J, Li J, Gong J.

J Exp Clin Cancer Res. 2015 Oct 13;34:119. doi: 10.1186/s13046-015-0233-7.

17.

Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.

Ljubimova JY, Lakhter AJ, Loksh A, Yong WH, Riedinger MS, Miner JH, Sorokin LM, Ljubimov AV, Black KL.

Cancer Res. 2001 Jul 15;61(14):5601-10.

18.

Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.

Leukemia. 2010 May;24(5):992-1000. doi: 10.1038/leu.2010.33. Epub 2010 Mar 18.

PMID:
20237505
19.

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.

Alonso MM, Diez-Valle R, Manterola L, Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, Lopez de Munain A, Sampron N, Aramburu A, Tejada-Solís S, Vicente C, Odero MD, Bandrés E, García-Foncillas J, Idoate MA, Lang FF, Fueyo J, Gomez-Manzano C.

PLoS One. 2011;6(11):e26740. doi: 10.1371/journal.pone.0026740. Epub 2011 Nov 1.

20.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

Supplemental Content

Support Center